Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nursery places for three-year-olds: introduction of free entitlement did not deliver long-term benefits for children?s development, new research finds

  • Boosting use of multi-sensory environments in dementia care

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • Exposure therapy appears helpful in treating patients with prolonged grief

  • Omega 3 can help children with ADD, experts say

  • Music therapy reduces depression in children, adolescents

  • Teens whose parents exert more psychological control have trouble with closeness, independence

  • Two days later: Adolescents' conflicts with family spill over to school, vice versa

  • If you're over 60, drink up: Alcohol associated with better memory

  • A new tune: There is intonation in sign language too

  •